Urinary fibrin split products in lupus nephritis

Area of Science:

• Nephrology
• Immunology
• Pathology

Background:

• Antigen-antibody complexes and fibrin deposition in lupus nephritis trigger fibrinolysis.
• Fibrinogen/fibrin split products (FSP) are markers of this process.
• Elevated urinary FSP may indicate active lupus nephritis.

Purpose of the Study:

• To investigate the prognostic value of urinary fibrinogen/fibrin split products (FSP) in lupus nephritis.
• To determine if persistent FSP excretion correlates with disease progression or renal outcomes.

Main Methods:

• A longitudinal study involving 27 patients with biopsy-proven lupus nephritis.
• Monitoring of urinary fibrinogen/fibrin split products (FSP) levels over time.
• Correlation of FSP excretion status with nephritis progression and renal death.

Main Results:

• Persistent FSP excretors showed a significantly higher risk of progressive nephritis.
• Patients with continuous FSP elevation faced a greater risk of renal death.
• FSP excretion is a grave prognostic sign, especially when other parameters normalize.

Conclusions:

• Urinary FSP levels are a valuable prognostic indicator in lupus nephritis.
• Persistent FSP excretion signifies poor outcomes, including disease progression and renal failure.
• Monitoring FSP can aid in risk stratification and management of lupus nephritis patients.